Average Co-Inventor Count = 5.56
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Melbourne Health (13 from 24 patents)
2. Austin Health (10 from 13 patents)
3. Southern Health (6 from 6 patents)
4. Abl Sa (4 from 6 patents)
5. St. Vincents Hospital (melbourne) Limited (3 from 5 patents)
6. Central Sydney Area Health Service (2 from 11 patents)
7. Alfred Health (2 from 5 patents)
8. Austin and Repatriation Medical Centre (2 from 2 patents)
9. Melbourne Health; St. Vincent's Hospital Melbourne; Austin Health (1 from 1 patent)
10. Melborne Health (1 from 1 patent)
19 patents:
1. 9702005 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
2. 9701982 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
3. 9682109 - Antiviral resistance mutants and applications thereof
4. 8592143 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
5. 8367317 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
6. 8273527 - Viral variants
7. 8211443 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
8. 8211633 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof
9. 8008000 - Viral variants detection and application
10. 7989162 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof
11. 7931907 - Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
12. 7887813 - Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
13. 7875423 - HBV variants detection and application
14. 7846663 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
15. 7745130 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof